Why Manufacturing Owners Should Consider Selling in 2026: The MARC SBA Window of Opportunity by Dr. Allen Nazeri M&AMI For U.S. manufacturing business owners, 2026 is shaping up to be one of the most favorable exit environments in recent history. A rare alignment of capital markets, buyer demand, and federal lending policy, driven in large part by the SBA’s Manufacturing and Access to Revolving Capital (MARC SBA) initiative, is materially improving how manufacturing acquisiti

If you're a business owner evaluating your exit strategy, 2026 may be your moment. After several years of macro volatility, we're entering a period of rare alignment between economic tailwinds, tax clarity, and capital abundance. While valuation multiples get the most attention, those in the M&A world know this truth well: the timing of your sale often has a greater impact on your final outcome than EBITDA or top-line revenue ever will. In this article, we explore how 2026 pr

Top 10 Reasons Why Sellers Reject Your Offer by Dr. Allen Nazeri DDS MBA Introduction If you've ever had your acquisition offer rejected by a seller, you're not alone. Whether you're a first-time buyer or a seasoned private equity firm, a Seller Rejected Offer situation can be confusing, frustrating, and even costly. In today’s competitive M&A landscape, especially in healthcare, dental, veterinary, and technology sectors, buyers must be aware of the key reasons why their pro

Why a Low Ball Offer Could Cost You More Than the Deal by Dr. Allen Nazeri Certified M&A Professional In the world of mergers and acquisitions, particularly in healthcare, credibility is everything. As intermediaries, we speak with hundreds of buyers every year. We see who’s serious—and who’s not—usually by their very first move. And nothing screams “not serious” louder than a Low Ball Offer or worse, a no-money-down offer. Let’s be clear: this isn’t about discouraging negoti

The Importance of Seller Patience in Healthcare M&A by Dr. Allen Nazeri DDS MBA When business owners decide to sell their companies, they often expect the process to move swiftly. However, the reality of Healthcare M&A is that it typically unfolds at a glacial pace. While some deals can close quickly, the average transaction takes four to six months, and larger, more complex deals can take even longer. Understanding and embracing this timeline is crucial for sellers to naviga

AI in Healthcare: The Good, The Bad, and The Ugly by Dr. Allen Nazeri CM&AP The healthcare industry is undergoing a transformative shift due to artificial intelligence (AI). While AI in healthcare offers the potential to improve efficiency, reduce costs, and enhance patient outcomes, it also brings significant challenges that impact employment, M&A transactions, and overall economic stability. The Good: How AI in Healthcare is Enhancing the Industry AI is revolutionizing heal

Healthcare Valuations Post-Tariffs by Dr. Allen Nazeri DDS MBA M&AMI Recent tariff implementations are poised to have widespread effects across multiple industries, including healthcare. From rising costs of medical equipment to supply chain disruptions, the impact on healthcare company valuations cannot be ignored. Investors, private equity firms, and strategic buyers must understand these changes to make informed decisions in the evolving M&A landscape. How Tariffs Affect H

Buyer Credibility in M&A by Dr. Allen Nazeri DDS MBA CM&AP In the intricate world of mergers and acquisitions (M&A), buyer credibility is not just a buzzword; it is the foundation on which successful deals are built. Whether you’re a private equity firm, strategic buyer, or an individual investor, your credibility can make or break your reputation within the tightly knit M&A community. For sellers and intermediaries, identifying serious buyers is critical to ensuring smooth a

Why Planning an Exit Is Essential: Lessons Learned from the LA Fire by Dr. Allen Nazeri DDS MBA The recent catastrophic wildfires in Los Angeles have once again demonstrated the unforgiving nature of unpredictable events. Whether in life or business, the necessity of planning ahead becomes undeniable when disaster strikes. Much like having a will ensures that loved ones are protected in the face of uncertainty, having a well-thought-out exit plan for your business safeguards

When it comes to private equity transactions, non-compete agreements are more than just a formality—they are a crucial part of protecting investments, maintaining competitive advantages, and ensuring a smooth transition after an acquisition. These agreements, which restrict the seller or key personnel from engaging in competitive activities against the company they sold, are vital for private equity firms aiming to secure their investments and minimize risks. Why Non-Compete

As the competition for investment opportunities heats up, many business owners are increasingly contemplating selling a portion of their companies to private equity (PE) firms. The infusion of capital into the market, combined with a limited number of lucrative investment opportunities, has made private equity an attractive option for business owners looking to grow, optimize, or even partially exit their businesses. This strategic move can unlock new resources, provide acce

When selling your company to private equity, negotiating an employment agreement is a critical aspect that can significantly impact your future role, compensation, and overall satisfaction. This article provides an in-depth look at the key considerations to keep in mind and the elements to watch out for during these negotiations. Understanding the Basics The Role of Employment Agreements An employment agreement is a legally binding document outlining the terms and conditions